233 related articles for article (PubMed ID: 36384523)
21. Antibiotic-Induced Dysbiosis of the Gut Microbiota Impairs Gene Expression in Gut-Liver Axis of Mice.
Liu P; Zhang Y; Zhang Z; Huang X; Su X; Yang S; Xie Y
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510327
[TBL] [Abstract][Full Text] [Related]
22. The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
Elkrief A; Derosa L; Kroemer G; Zitvogel L; Routy B
Ann Oncol; 2019 Oct; 30(10):1572-1579. PubMed ID: 31268133
[TBL] [Abstract][Full Text] [Related]
23. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
Derosa L; Routy B; Fidelle M; Iebba V; Alla L; Pasolli E; Segata N; Desnoyer A; Pietrantonio F; Ferrere G; Fahrner JE; Le Chatellier E; Pons N; Galleron N; Roume H; Duong CPM; Mondragón L; Iribarren K; Bonvalet M; Terrisse S; Rauber C; Goubet AG; Daillère R; Lemaitre F; Reni A; Casu B; Alou MT; Alves Costa Silva C; Raoult D; Fizazi K; Escudier B; Kroemer G; Albiges L; Zitvogel L
Eur Urol; 2020 Aug; 78(2):195-206. PubMed ID: 32376136
[TBL] [Abstract][Full Text] [Related]
24. Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer.
Iglesias-Santamaría A
Clin Transl Oncol; 2020 Sep; 22(9):1481-1490. PubMed ID: 31919759
[TBL] [Abstract][Full Text] [Related]
25. The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors.
Zhou J; Huang G; Wong WC; Hu DH; Zhu JW; Li R; Zhou H
Front Immunol; 2022; 13():968729. PubMed ID: 35967438
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer.
Zhang F; Ferrero M; Dong N; D'Auria G; Reyes-Prieto M; Herreros-Pomares A; Calabuig-Fariñas S; Duréndez E; Aparisi F; Blasco A; García C; Camps C; Jantus-Lewintre E; Sirera R
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34063829
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
28. Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence.
Vallianou N; Dalamaga M; Stratigou T; Karampela I; Tsigalou C
Curr Obes Rep; 2021 Sep; 10(3):244-262. PubMed ID: 33945146
[TBL] [Abstract][Full Text] [Related]
29. Chronological analysis of the gut microbiome for efficacy of atezolizumab-based immunotherapy in non-small cell lung cancer: Protocol for a multicenter prospective observational study.
Shoji F; Miura N; Tagawa T; Tsukamoto S; Okamoto T; Yamazaki K; Hamatake M; Takeo S
Thorac Cancer; 2022 Oct; 13(19):2829-2833. PubMed ID: 36063818
[TBL] [Abstract][Full Text] [Related]
30. Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors.
Elkrief A; El Raichani L; Richard C; Messaoudene M; Belkaid W; Malo J; Belanger K; Miller W; Jamal R; Letarte N; Wong P; Routy B
Oncoimmunology; 2019; 8(4):e1568812. PubMed ID: 30906663
[No Abstract] [Full Text] [Related]
31. Detailed Characterization of the Lung-Gut Microbiome Axis Reveals the Link between PD-L1 and the Microbiome in Non-Small-Cell Lung Cancer Patients.
Ankudavicius V; Nikitina D; Lukosevicius R; Tilinde D; Salteniene V; Poskiene L; Miliauskas S; Skieceviciene J; Zemaitis M; Kupcinskas J
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396998
[TBL] [Abstract][Full Text] [Related]
32. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.
Zhang C; Wang J; Sun Z; Cao Y; Mu Z; Ji X
Cancer Sci; 2021 Aug; 112(8):3005-3017. PubMed ID: 34028936
[TBL] [Abstract][Full Text] [Related]
33. Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer.
Qiu B; Xi Y; Liu F; Li Y; Xie X; Guo J; Guo S; Wu Y; Wu L; Liang T; Ding Y; Zhang J; Wu Q; Liu H
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):407-418. PubMed ID: 35905860
[TBL] [Abstract][Full Text] [Related]
34. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
[TBL] [Abstract][Full Text] [Related]
35. How to Choose a Survival Period? The Impact of Antibiotic Use on OS or PFS in NSCLC Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Chen H; Han KD; He ZJ; Huang YS
Technol Cancer Res Treat; 2021; 20():15330338211033498. PubMed ID: 34323149
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Gut Microbiota Signature and Microbe-Disease Progression Associations in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy.
Xi Y; Liu F; Qiu B; Li Y; Xie X; Guo J; Wu L; Liang T; Wang D; Wang J; Chen M; Xue L; Ding Y; Zhang J; Wu Q; Liu H
Front Cell Infect Microbiol; 2022; 12():892401. PubMed ID: 35719339
[TBL] [Abstract][Full Text] [Related]
37. The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors.
Joachim L; Göttert S; Sax A; Steiger K; Neuhaus K; Heinrich P; Fan K; Orberg ET; Kleigrewe K; Ruland J; Bassermann F; Herr W; Posch C; Heidegger S; Poeck H
EBioMedicine; 2023 Nov; 97():104834. PubMed ID: 37865045
[TBL] [Abstract][Full Text] [Related]
38. Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer.
Liu F; Li J; Guan Y; Lou Y; Chen H; Xu M; Deng D; Chen J; Ni B; Zhao L; Li H; Sang H; Cai X
Int J Biol Sci; 2019; 15(11):2381-2392. PubMed ID: 31595156
[TBL] [Abstract][Full Text] [Related]
39. Impact of Gut Dysbiosis on the Risk of Non-Small-Cell Lung Cancer.
Wei YF; Huang MS; Huang CH; Yeh YT; Hung CH
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498063
[TBL] [Abstract][Full Text] [Related]
40. Depletion of Gut Microbiota Impairs Gut Barrier Function and Antiviral Immune Defense in the Liver.
Guo W; Zhou X; Li X; Zhu Q; Peng J; Zhu B; Zheng X; Lu Y; Yang D; Wang B; Wang J
Front Immunol; 2021; 12():636803. PubMed ID: 33841420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
